Addgene: Pyrimidine metabolic rate limiting enzymes in poorly-differentiated hepatocellular carcinoma are signature genes of cancer stemness and associated with poor prognosis.

This website uses cookies to ensure you get the best experience. By continuing to use this site, you agree to the use of cookies.

Please note: Your browser does not support the features used on Addgene's website. You may not be able to create an account or request plasmids through this website until you upgrade your browser. Learn more

Please note: Your browser does not fully support some of the features used on Addgene's website. If you run into any problems registering, depositing, or ordering please contact us at [email protected]. Learn more

Browse
Yuh-Shan Jou
Yeh et al

Pyrimidine metabolic rate limiting enzymes in poorly-differentiated hepatocellular carcinoma are signature genes of cancer stemness and associated with poor prognosis.
Yeh HW, Lee SS, Chang CY, Hu CM, Jou YS
Oncotarget. 2017 Sep 8;8(44):77734-77751. doi: 10.18632/oncotarget.20774. eCollection 2017 Sep 29. PubMed Article

Plasmids from Article

ID	Plasmid	Purpose
100544	pcDNA3.1-TK1	mammalian expression of thymidine kinase 1
100545	pcDNA3.1-TYMS	mammalian expression of thymidylate synthetase
100546	pcDNA3.1-DTYMK	mammalian expression of deoxythymidylate kinase

Plasmids from Article

Antibodies from Article

Help Center

Deposit Plasmids

General Reagents

Viral Service

DNA Service

Plasmid Collections

	More than 20 requests
	More than 50 requests
	More than 100 requests